title: Successful treatment of high-risk acute promyelocytic leukemia in very elderly patients using all-trans retinoic acid plus reduced-dose idarubicin.
authors.affiliation: Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
authors.forename: Takao
authors.initials: T
authors.lastname: Fujisawa
authors.forename: June
authors.initials: J
authors.lastname: Takeda
authors.forename: Kazunari
authors.initials: K
authors.lastname: Aoki
authors.forename: Takayuki
authors.initials: T
authors.lastname: Ishikawa
mesh_terms: D000367:Age Factors; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy* / Q000473:pathology; D012306:Risk; D016896:Treatment Outcome; D014212:Tretinoin / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D014212:Tretinoin; D015255:Idarubicin